FDA Product Jurisdiction Review Requests Nearly Double
This article was originally published in The Pink Sheet Daily
Executive Summary
Request designations, which mostly involve drug/device combinations, grew at a higher rate than the overall number of contacts with the CDER ombudsman. Phone calls also ballooned in 2004. "Hot topics" include importation, Plan B and drug safety.